SuviCa Inc. of Boulder and CU-Boulder completed an exclusive license agreement for a CU drug screening technology to identify novel therapies for cancer.
The patented drug discovery tool, developed by Professor Tin Tin Su of the molecular, cellular, and developmental biology (MCDB) department, uses a genetically modified Drosophila fruit fly model to screen for compounds effective against various types of cancer, either alone or in combination with existing therapies.